Literature DB >> 31162091

Should we stop investing in chemoprevention trials in oncology?

David Weller, Richard C Wender.   

Abstract

Year:  2019        PMID： 31162091     DOI： 10.1016/S1470-2045(19)30302-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

Review 1.  Strategies for Testing Intervention Matching Schemes in Cancer.

Authors:  Nicholas J Schork; Laura H Goetz; James Lowey; Jeffrey Trent
Journal:  Clin Pharmacol Ther       Date:  2020-07-24       Impact factor: 6.875
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.